Metastatic cancer to the stomach
Autor: | Márcio Martins Machado, Flávio Hayato Ejima, Daniela Medeiros Milhomem Cardoso, Orlando Milhomem da Mota, Osterno Queiroz da Silva, Jales Benevides Santana Filho, Eliane Duarte Mota, João Alves Araujo Filho, Paulo Moacir de Oliveira Campoli, Rita de Cássia Gonçalves Alencar, Paulo Adriano de Queiroz Barreto |
---|---|
Rok vydání: | 2006 |
Předmět: |
Adult
Male Cancer Research medicine.medical_specialty Gastroenterology Metastasis Neoplasm Seeding Stomach Neoplasms Surgical oncology Neoplasms Internal medicine medicine Humans Endoscopy Digestive System Survival rate Aged Aged 80 and over medicine.diagnostic_test Esophagogastroduodenoscopy business.industry Stomach Cancer General Medicine Middle Aged medicine.disease Endoscopy Survival Rate medicine.anatomical_structure Oncology Female business Abdominal surgery |
Zdroj: | Gastric Cancer. 9:19-25 |
ISSN: | 1436-3305 1436-3291 |
DOI: | 10.1007/s10120-005-0352-5 |
Popis: | Metastases in the stomach are rare. The increased use of esophagogastroduodenoscopy (EGD), associated with better treatment results for malignancies, requires them to be acknowledged. The aim of this study was to describe a series of cases of metastasis to the stomach, their primary sites, clinical and endoscopic features, treatment, and results.Twenty cases were diagnosed between December 1999 and January 2004. Their analysis included symptomatology, macroscopic presentation, time from diagnosis of the primary tumor to the detection of the gastric metastasis, treatment approach, and survival.The primary sites were the esophagus, skin, lung, cervix, breast, sigmoid colon, and testis. The symptom most frequently requiring EGD was upper gastrointestinal bleeding. Ten patients showed concomitant metastases to other organs. The mean time between diagnosis of the primary tumor and diagnosis of gastric metastasis was 16 months (range, 0 to 56 months). Only seven patients were given some form of treatment after diagnosis of the gastric metastasis. The median survival was 4.75 months. Overall survival during the first year was 20% and survival was nil at 2 years.Gastric metastasis marks advanced disease and the prognosis is poor. New advances in diagnosis and treatment are required for better results. |
Databáze: | OpenAIRE |
Externí odkaz: |